Prognia
Drug Database
🇪🇺EU · EMAApplication withdrawnATC: M05BB03

Alendronic Acid / Colecalciferol Mylan(alendronate sodium trihydrate;colecalciferol)

Osteoporosis

Marketing Authorisation Holder: Mylan S.A.S.

Indication

Treatment of postmenopausal osteoporosis

Official EMA Resources

View on EMA (ema.europa.eu)

AI Drug & Interaction Analysis

Free account required

Ask Prognia AI about Alendronic Acid / Colecalciferol Mylan — dosing recommendations, drug interactions, and current guideline evidence from ESC, EMA, NICE and more.

Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.